BioProtect

Tzur Yigal, Israel · Founded 2004 · Acquired/Merged (Operating Subsidiary)

Developer of a pro-space balloon system designed to safely and temporarily separate the rectum during prostate cancer radiation therapy. BioProtect is based in Tzur Yigal, Israel and was founded in 2004. Its last known valuation is $200 million (Jan 2026). It has raised $67.9 million.

Last price · $/share

—

Implied valuation

$200.0M

Total raised

$67.9M

Last round

—

How much has BioProtect raised?

$67.9Macross 0 recorded rounds

Free account

More of BioProtect with a free account

·The complete investor list: 21 names
·Watch BioProtect: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

BioProtect investors

21 investors are on record for BioProtect, including KB Investment, Innovation Authority, Peregrine Ventures and Consensus Business Group.

For fundraisers

Raising for a company like BioProtect?

21 investors have backed BioProtect.

See all 21 investors →

Frequently asked about BioProtect

How much has BioProtect raised?: BioProtect has raised $67.9M in total across 0 recorded funding rounds.